Pensions & Investments Logo
ETF Exchange > HELX ETF

HELX - ETF Fact Sheet

Franklin Genomic Advancements ETF - USD

Fund Identification

Ticker

HELX

ISIN

US35473P5200

Main Metrics

Price

$31.26

Expense Ratio

0.5%

AuM

$20.32M

Tracking Difference

%

Ratings

Trackinsight rating

N/A

ESG Consensus®

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise

Official Investment Strategy

The Fund seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life.

HELX's historical prices, performance, and flows

-10.0-8.0-6.0-4.0-2.00.0%
1m returns
-10%
1m flows
$0M
* Net total returns
All data as of 27 March 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all HELX data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

HELX's characteristics

Manager statistics

149 funds, $53.12Bn in AUM

Asset class

Equity

Dividend policy

Distributing

Meets ESG criteria

No

HELX's exposure

The HELX ETF is actively managed, so it doesn't track an index. We're working to retrieve all detailed holding information.

0.0%